Cargando...
Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy
Breast cancer remains a leading cause of cancer-related death internationally. Treatment approaches for metastatic breast cancer have evolved in recent years; however chemotherapy remains a core component for the majority of patients. Agents such as anthracyclines and taxanes have been extensively s...
Gardado en:
| Publicado en: | Int J Womens Health |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4294649/ https://ncbi.nlm.nih.gov/pubmed/25610001 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJWH.S74462 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|